Month: July 2020

CHARLESTON, S.C., July 31, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the filing of two patent applications on July 22, 2020 related to its substance macimorelin, an orally available ghrelin agonist to be used in the diagnosis of patients with adult growth hormone deficiency (“AGHD”) and childhood-onset growth hormone deficiency (“CGHD”).Based on the positive results from AEZS-130-P01 (“Study P01”) evaluating macimorelin as a growth hormone stimulation test for the evaluation of CGHD, the Company filed a U.S. provisional application as well as a patent application under PCT (Patent Cooperation Treaty). Both patent applications relate to the invention of...

Orphazyme A/SCompany announcement                                                                                       No. 44/2020                                                                                                          Company Registration No. 32266355Copenhagen, Denmark, July 31, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company harnessing the amplification of the Heat-Shock Protein in order to develop and commercialize novel therapeutics for the treatment of neurodegenerative orphan diseases, today announces that a share capital increase has been registered with the Danish Business Authority as a result of the vesting and exercise of Matching Shares. A total of 31,250 shares of nominally DKK 1 each have been issued by the Company at a subscription price per Matching Share of DKK 1.Reference is...

PHILADELPHIA and NICOSIA, Cyprus, July 31, 2020 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), the global leader in managing construction risk, announced today that it was selected by the Natural Gas Infrastructure Company of Cyprus (ETYFA) to lead an international consortium and provide owner’s engineer services in connection with the Cyprus Liquefied Natural Gas (LNG) Import Terminal Project, the nation’s largest and most anticipated energy project.With a budget of over €289 million ($336 million) and an implementation timeframe of 24 months, the project will be constructed at Vasilikos Bay on the southern coast of Cyprus. It represents the beginning of a new energy era for Cyprus, bringing to fruition years of the nation’s efforts to end energy isolation, ensure diversification of energy sources, strengthen the security of...

WARSAW, N.Y., July 31, 2020 (GLOBE NEWSWIRE) — Five Star Bank (the “Bank”), subsidiary of Financial Institutions, Inc. (NASDAQ:FISI), announced today that Kevin Quinn will be joining the Bank on August 10th as Senior Vice President and Commercial Banking Executive. Quinn will report to President and CEO, Martin K. Birmingham. Quinn will assume responsibility for commercial and industrial lending, business banking, cash management, community development and merchant services as well as leadership of Five Star Bank’s referral program, promoting relationship-building and business development between the Bank and its insurance and wealth management subsidiaries.   Birmingham said, “We are pleased to welcome Kevin Quinn to Five Star Bank. He is a respected banker and community leader. His experience, capability, character and deep understanding...

NEW YORK, July 31, 2020 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed pharmaceutical products and development-stage pharmaceutical product candidates, today announced that the European Medicines Agency (“EMA”) Committee for Orphan Medicinal Products issued a positive opinion on Cyprium Therapeutics’ (“Cyprium”) application for Orphan Drug Designation for Copper Histidinate, also referred to as CUTX-101, a potential treatment for Menkes disease. Menkes disease is an often lethal, if untreated, X-linked recessive disorder of copper metabolism caused by mutations in ATP7A, an evolutionarily conserved copper-transporting ATPase. The U.S. Food and Drug Administration (“FDA”) previously granted...

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”) wishes to report that Mr. Michael Kadonoff has left the Company as President, Chief Executive Officer and a director. The Company thanks Mr. Kadonoff for his past service and contributions.About Braingrid:Braingrid is a global technology company committed to the best interests of the precision agriculture industry for the long term. We provide valuable grow analytics by capturing real-time data using our technology platform to increase revenues, reduce costs, risks and improve yield – making it easier for the grower to operate efficiently and effectively. Braingrid is listed on the CSE under the symbol BGRD.The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.Media Contact:Braingrid...

SANTA CLARA, Calif., July 31, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. will hold a webcast to discuss its third quarter of fiscal 2020 financial results on Thursday, Aug. 13, 2020 at 4:30 p.m. ET / 1:30 p.m. PT.The live webcast will be accessible via the Applied Materials website at: http://www.appliedmaterials.com/company/investor-relations. A replay will be available on the same day beginning at 8:00 p.m. ET / 5:00 p.m. PT.About Applied MaterialsApplied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible the technology shaping the...

JERSEY CITY, N.J., July 31, 2020 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer and provider of products that power, protect and connect electronic circuits, today announced preliminary financial results for the second quarter of 2020.Second Quarter 2020 HighlightsNet sales of $121.2 million, down 4.9% from Q2-19Gross profit margin of 26.2%, up from 21.0% in Q2-19Net earnings of $5.6 million, as compared with net earnings of $3.0 million in Q2-19GAAP EPS of $0.43 per Class A share (versus $0.23 in Q2-19) and $0.46 per Class B share (versus $0.24 in Q2-19)Non-GAAP EPS of $0.43 per Class A share (versus $0.03 in Q2-19) and $0.46 per Class B share (versus $0.03 in Q2-19)Backlog of $179.6 million at June 30, 2020, up 12% from year-endCash flow provided by operating activities of $8.8 millionNon-GAAP...

TORONTO, July 31, 2020 (GLOBE NEWSWIRE) — Further to the announcement made June 1, 2020, AGF Management Limited (TSX:AGF.B) confirms that Smith & Williamson shareholders have voted and approved the merger between Tilney and Smith & Williamson creating one of the U.K’s leading integrated wealth management and professional services group.Further, the Financial Conduct Authority (FCA) have approved the merger. All relevant third-party conditions to complete the merger, including the FCA condition, have now been satisfied. Smith & Williamson will now seek the U.K. High Court’s sanction of the merger at a hearing on August 6, 2020. Subject to the Court sanctioning the merger at the hearing on August 6, 2020, the transaction is now expected to complete on September 1, 2020.ABOUT AGF MANAGEMENT LIMITED 

TORONTO, 31 juill. 2020 (GLOBE NEWSWIRE) — Pour faire suite à l’annonce du 1er juin 2020, La Société de Gestion AGF Limitée (TSX : AGF.B) (« AGF ») confirme que les actionnaires de Smith & Williamson ont voté en faveur de la fusion de Tilney et de Smith & Williamson, laquelle vise à créer un groupe de premier plan spécialisé dans le domaine des services professionnels et de la gestion intégrée de patrimoine au Royaume-Uni.En outre, la Financial Conduct Authority (FCA) du Royaume-Uni a approuvé la fusion. Toutes les conditions de tiers pertinentes pour la réalisation de la fusion, y compris la condition de la FCA, sont remplies. Smith & Williamson demandera maintenant au tribunal de première instance du Royaume-Uni de sanctionner la fusion dans le cadre d’une audience qui aura lieu le 6 août 2020. Sous réserve de l’approbation...